Literature DB >> 23537078

Possible role of NUCB2/nesfatin-1 in adipogenesis.

Manjunath Ramanjaneya1, Melisande Addison, Harpal S Randeva.   

Abstract

NUCB2 and its proteolytically cleaved product nesfatin-1 were initially identified as hypothalamic neuroproteins that inhibit food intake, via a leptin-independent pathway. Since then recent studies have found NUCB2/nesfatin-1 to be expressed both centrally, as well as in peripheral tissues. The recent implementation of novel experimental approaches has produced a large body of evidence implicating NUCB2/nesfatin-1 in a diverse range of biological functions and in the modulation of food intake, energy homeostasis and metabolism. In this review, we discuss the discovery of NUCB2 and its proteolytic product nesfatin-1, and its expression in both central and peripheral tissues. In addition we shed light on the most recent discoveries supporting the role for NUCB2/nesfatin-1 in peripheral tissues and its association with metabolic alterations. Moreover, we highlight the importance of NUCB2 and nesfatin-1 in adipose tissue, its regulation of adipogenesis and obesity-associated metabolic diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537078     DOI: 10.2174/138161281939131127142959

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  Zinc Supplementation Improved Neuropeptide Y, Nesfatin-1, Leptin, C-reactive protein, and HOMA-IR of Diet-Induced Obese Rats.

Authors:  Şule Demirci; Cennet Gün
Journal:  Biol Trace Elem Res       Date:  2021-10-27       Impact factor: 4.081

Review 2.  Brain peptides and the modulation of postoperative gastric ileus.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Opin Pharmacol       Date:  2014-07-09       Impact factor: 5.547

Review 3.  Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-12-12       Impact factor: 3.633

4.  SERUM NESFATIN-1 LEVEL IN HEALTHY SUBJECTS WITH WEIGHT-RELATED ABNORMALITIES AND NEWLY DIAGNOSED PATIENTS WITH TYPE 2 DIABETES MELLITUS; A CASE-CONTROL STUDY.

Authors:  S Mirakhor Samani; H Ghasemi; K Rezaei Bookani; B Shokouhi
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.